ABSTRACT
Recently, professional and healthcare-related entities have launched frameworks designed to assess the value of cancer innovations in multistakeholder decision processes. Among the most visible entities that propose and implement value frameworks in oncology are the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Memorial Sloan Kettering Cancer Center (MSKCC) and the National Comprehensive Cancer Network (NCCN). However, these value frameworks have been criticized for conceptual inconsistencies, inability to include a greater variety of value criteria, and inadequate explanation of the uncertainty approach used in the modeling process. On the other hand, Multi-Criteria Decision Analysis (MCDA) is a set of methods and processes that allow the multiple criteria involved in a decision to be explicitly addressed. This approach allows the identification of relevant decision criteria, gathering of evidence based on scientific literature, attribution of weights to the criteria and scores to the evidence raised, and aggregation of the weighted scores to constitute a global metric of value. The purpose of this article is to review the main features of these value frameworks in oncology and the importance of perspective for framework readiness to support healthcare decision-making based on MCDA methodology.
Subject(s)
Humans , Decision Support Systems, Clinical/standards , Clinical Decision-Making/methods , Medical Oncology/standards , Reference Standards , Cost-Benefit Analysis , Decision Support Systems, Clinical/economics , Delivery of Health Care/economics , Delivery of Health Care/standards , Medical Oncology/economicsABSTRACT
OBJECTIVE: Non-communicable Diseases (NCDs) are leading threats to health and well-being in the Caribbean. A study was undertaken in the latter part of 2005 to compute the economic burden of diabetes mellitus and hypertension within the Caribbean Community and Common Market (CARICOM). This report critiques the quality and availability of health information which can be used to facilitate cost burden analysis of diabetes mellitus and hypertension. METHODS: A form was developed and disseminated to obtain epidemiological and health service utilization data. Subsequent visits were made to seven CARICOM member countries to collect the data. RESULTS: The results revealed (i) a number of deficiencies in the reliability and validity of the data received, in particular, those needed to facilitate the analysis of cost-specific complications such as ischaemic heart disease, cerebrovascular disease, chronic renal failure, hypertensive and diabetic retinopathy and peripheral circulatory complications; (ii) data management systems in hospitals were not linked to facilitate generation of cost-effectiveness estimates and other information required to compare options for health investment; (iii) despite repeated attempts by regional governments to develop/strengthen Health Information Systems within the Caribbean, sustainability has been significantly hampered by human, material and financial resource constraints and ongoing monitoring and evaluation is generally poor. CONCLUSION: There are deficiencies in the quality and availability of health information to facilitate cost burden analysis of hypertension and diabetes mellitus in the Caribbean. Strong commitment from CARICOM governments will be necessary to address these concerns if economic evaluations are to be undertaken more frequently as part of the effort to reduce the morbidity and mortality from these diseases.
OBJETIVO: Las enfermedades no comunicables (ENC) se cuentan entre las principales amenazas a la salud y el bienestar en el Caribe. Se llevó a cabo un estudio hacia finales de 2005, con el fin de computar la carga económica de la diabetes mellitus y la hipertensión dentro de la Comunidad y el Mercado Común del Caribe (CARICOM). Este reporte constituye un análisis crítico de la calidad y disponibilidad de información sobre la salud, que puede ser usada para facilitar el análisis del nivel de costos de la diabetes mellitus y la hipertensión. MÉTODOS: Se desarrolló y distribuyó un formulario para obtener datos acerca de la utilización de servicios de salud y servicios epidemiológicos. Posteriormente se realizaron visitas a siete países miembros de CARICOM con el propósito de recoger datos. RESULTADOS: Los resultados revelaron (i) algunas deficiencias en cuanto a la confiabilidad y la validez de los datos recibidos, en particular los necesarios para facilitar el análisis de las complicaciones costo-específicas, tales como la enfermedad cardíaca isquémica, la enfermedad cerebrovascular, el fallo renal crónico, la retinopatía hipertensiva y diabética, y las complicaciones circulatorias periféricas; (ii) los sistemas de administración de datos en los hospitales no estaban conectados para facilitar la producción de estimados de costo-efectividad y otras informaciones requeridas para comparar las opciones de inversión para la salud; (iii) a pesar de reiterados intentos de los gobiernos regionales por desarrollar y fortalecer los sistemas de información de salud en el área del Caribe, su sostenimiento ha sido obstaculizado significativamente a causa de restricciones en cuanto a recursos humanos, materiales y financieros, y por el hecho de que el monitoreo y la evaluación actuales son generalmente pobres. CONCLUSIÓN: Existen deficiencias en la calidad y disponibilidad de información sobre la salud, en cuanto a facilitar el análisis del nivel de la magnitud del costo de la hipertensión y la diabetes mellitus en el Caribe. Será necesario un fuerte compromiso por parte de los gobiernos del CARICOM para abordar estos problemas, si se ha de emprender evaluaciones económicas con mayor frecuencia, como parte del esfuerzo por reducir la morbilidad y la mortalidad por estas enfermedades.